![The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain | SpringerLink The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10067-014-2517-2/MediaObjects/10067_2014_2517_Fig1_HTML.gif)
The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain | SpringerLink
![Use of low-dose naltrexone in the management of chronic pain conditions: A systematic review - ScienceDirect Use of low-dose naltrexone in the management of chronic pain conditions: A systematic review - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002817720306346-fx1.jpg)
Use of low-dose naltrexone in the management of chronic pain conditions: A systematic review - ScienceDirect
![Changes in the consumption of antiepileptics and psychotropic medicines after starting low dose naltrexone: A nation-wide register-based controlled before-after study | Scientific Reports Changes in the consumption of antiepileptics and psychotropic medicines after starting low dose naltrexone: A nation-wide register-based controlled before-after study | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-019-51569-z/MediaObjects/41598_2019_51569_Fig2_HTML.png)
Changes in the consumption of antiepileptics and psychotropic medicines after starting low dose naltrexone: A nation-wide register-based controlled before-after study | Scientific Reports
Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study | PLOS ONE
Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study | PLOS ONE
![Use of low-dose naltrexone in the management of chronic pain conditions: A systematic review - ScienceDirect Use of low-dose naltrexone in the management of chronic pain conditions: A systematic review - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002817720306346-gr1.jpg)
Use of low-dose naltrexone in the management of chronic pain conditions: A systematic review - ScienceDirect
![Study protocol for a randomised, double-blinded, placebo-controlled phase III trial examining the add-on efficacy, cost–utility and neurobiological effects of low-dose naltrexone (LDN) in patients with fibromyalgia (INNOVA study) | BMJ Open Study protocol for a randomised, double-blinded, placebo-controlled phase III trial examining the add-on efficacy, cost–utility and neurobiological effects of low-dose naltrexone (LDN) in patients with fibromyalgia (INNOVA study) | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/12/1/e055351/F1.large.jpg)
Study protocol for a randomised, double-blinded, placebo-controlled phase III trial examining the add-on efficacy, cost–utility and neurobiological effects of low-dose naltrexone (LDN) in patients with fibromyalgia (INNOVA study) | BMJ Open
![Frontiers | Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment Frontiers | Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment](https://www.frontiersin.org/files/Articles/687806/fimmu-12-687806-HTML/image_m/fimmu-12-687806-g001.jpg)